このアイテムのアクセス数: 36

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41467-024-53533-6.pdf5.91 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorShionoya, Kahoen
dc.contributor.authorPark, Jae-Hyunen
dc.contributor.authorEkimoto, Toruen
dc.contributor.authorTakeuchi, Junko S.en
dc.contributor.authorMifune, Junkien
dc.contributor.authorMorita, Takeshien
dc.contributor.authorIshimoto, Naitoen
dc.contributor.authorUmezawa, Harukaen
dc.contributor.authorYamamoto, Kenichiroen
dc.contributor.authorKobayashi, Chisaen
dc.contributor.authorKusunoki, Atsutoen
dc.contributor.authorNomura, Norimichien
dc.contributor.authorIwata, Soen
dc.contributor.authorMuramatsu, Masamichien
dc.contributor.authorTame, Jeremy R. H.en
dc.contributor.authorIkeguchi, Mitsunorien
dc.contributor.authorPark, Sam-Yongen
dc.contributor.authorWatashi, Koichien
dc.contributor.alternative塩野谷, 果歩ja
dc.contributor.alternative朴, 在鉉ja
dc.contributor.alternative浴本, 亨ja
dc.contributor.alternative竹内, 潤子ja
dc.contributor.alternative御舩, 淳紀ja
dc.contributor.alternative森田, 武志ja
dc.contributor.alternative石本, 直偉士ja
dc.contributor.alternative梅澤, 遥佳ja
dc.contributor.alternative山本, 健一郎ja
dc.contributor.alternative小林, ちさja
dc.contributor.alternative楠, 温登ja
dc.contributor.alternative野村, 紀通ja
dc.contributor.alternative岩田, 想ja
dc.contributor.alternative村松, 正道ja
dc.contributor.alternative池口, 満徳ja
dc.contributor.alternative朴, 三用ja
dc.contributor.alternative渡士, 幸一ja
dc.date.accessioned2024-12-03T02:39:48Z-
dc.date.available2024-12-03T02:39:48Z-
dc.date.issued2024-10-25-
dc.identifier.urihttp://hdl.handle.net/2433/290674-
dc.descriptionサルはなぜB型肝炎ウイルスに感染しないのか --ウイルス感染の「種間の壁」が生じる要因を解明--. 京都大学プレスリリース. 2024-12-03.ja
dc.description.abstractMacaque restricts hepatitis B virus (HBV) infection because its receptor homologue, NTCP (mNTCP), cannot bind preS1 on viral surface. To reveal how mNTCP loses the viral receptor function, we here solve the cryo-electron microscopy structure of mNTCP. Superposing on the human NTCP (hNTCP)-preS1 complex structure shows that Arg158 of mNTCP causes steric clash to prevent preS1 from embedding onto the bile acid tunnel of NTCP. Cell-based mutation analysis confirms that only Gly158 permitted preS1 binding, in contrast to robust bile acid transport among mutations. As the second determinant, Asn86 on the extracellular surface of mNTCP shows less capacity to restrain preS1 from dynamic fluctuation than Lys86 of hNTCP, resulting in unstable preS1 binding. Additionally, presence of long-chain conjugated-bile acids in the tunnel induces steric hindrance with preS1 through their tailed-chain. This study presents structural basis in which multiple sites in mNTCP constitute a molecular barrier to strictly restrict HBV.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.rights© The Author(s) 2024en
dc.rightsThis article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectCryoelectron microscopyen
dc.subjectHepatitis B virusen
dc.titleStructural basis for hepatitis B virus restriction by a viral receptor homologueen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleNature Communicationsen
dc.identifier.volume15-
dc.relation.doi10.1038/s41467-024-53533-6-
dc.textversionpublisher-
dc.identifier.artnum9241-
dc.addressDepartment of Virology II, National Institute of Infectious Diseases; Graduate School of Science and Technology, Tokyo University of Science; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University; Department of Molecular Cell Biology, Sungkyunkwan University School of Medicineen
dc.addressComputational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City Universityen
dc.addressCenter for Clinical Sciences, National Center for Global Health and Medicineen
dc.addressResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City Universityen
dc.addressDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City Universityen
dc.addressComputational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City Universityen
dc.addressDepartment of Virology II, National Institute of Infectious Diseases; Graduate School of Science and Technology, Tokyo University of Science; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressResearch Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.addressDepartment of Cell Biology, Graduate School of Medicine, Kyoto Universityen
dc.addressDepartment of Cell Biology, Graduate School of Medicine, Kyoto University; RIKEN SPring-8 Centeren
dc.addressDepartment of Virology II, National Institute of Infectious Diseases; Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobeen
dc.addressDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City Universityen
dc.addressComputational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City University; HPC- and AI-driven Drug Development Platform Division, Center for Computational Science, RIKENen
dc.addressDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City Universityen
dc.addressDepartment of Virology II, National Institute of Infectious Diseases; Graduate School of Science and Technology, Tokyo University of Science; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseasesen
dc.identifier.pmid39455604-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2024-12-03-0-
dcterms.accessRightsopen access-
dc.identifier.eissn2041-1723-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons